Svetlana Doronina

This inventor holds 32 USPTO granted patents and 9 published patent applications, plus 4 CIPO patents and 8 EPO patents, primarily in Antibody-Drug Conjugates. Top assignees: Seattle Genetics, Inc., Seagen Inc.. Active years: 2005-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Svetlana Doronina. Retrieved from https://idiyas.com/inventor/svetlana-doronina

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 32 (Patent Applications = 9)

% Patents Active = 96.9

CIPO Patents = 4 (Patent Applications = 6)

EPO Patents = 8 (Patent Applications = 9)

Average Co-Inventor Count = 3.2

ph-index = 20

Forward Citations = 2,317(Granted Patents)

Location History:

Bothell, WA (US) (2005 - 2006)
Snohomish, WA (US) (2007 - 2024)

Company Filing History:

28 out of 132

Seattle Genetics, Inc.

Years Active: 2005-2025

Loading Chart...

Areas of Expertise:

Antibody-Drug Conjugates

Monomethylvaline Compounds

Auristatin Linker Conjugates

Self-Stabilizing Linkers

Cancer Treatment

Autoimmune Disease

Infectious Disease

Phenylalanine Modifications

Pentapeptide Compounds

Ligand Conjugation

Drug Resistance

Humanized Antibodies

32 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12257281 - Hydrophilic antibody-drug conjugates (2025-03-25),

2. 11857565 - Hydrophobic Auristatin F compounds and conjugates thereof (2024-01-02),

3. 11510959 - Hydrophilic antibody-drug conjugates (2022-11-29),

4. 10933112 - Hydrophilic antibody-drug conjugates (2021-03-02),

5. 10808039 - Monomethylvaline compounds capable of conjugation to ligands (2020-10-20),

6. 10414826 - Monomethylvaline compounds capable of conjugation to ligands (2019-09-17),

7. 10000555 - Monomethylvaline compounds having phenylalanine side-chain modification at the C-terminus (2018-06-19),

8. 9522194 - Methods of using monomethylvaline compositions having phenylalanine carboxy modifications at the C-terminus (2016-12-20),

9. 9504756 - Self-stabilizing linker conjugates (2016-11-29),

10. 9463252 - Auristatin drug linker conjugates (2016-10-11),

11. 8906376 - Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease (2014-12-09),

12. 8871720 - Monomethylvaline compounds having phenylalanine carboxy modifications at the C-terminus (2014-10-28),

13. 8703714 - Monomethylvaline compounds capable of conjugation to ligands (2014-04-22),

14. 8609105 - Auristatin drug linker conjugates (2013-12-17),

15. 8557780 - Monomethylvaline compounds capable of conjugation to ligands (2013-10-15),

Title: The Innovative Journey of Inventor Svetlana Doronina

Introduction: Svetlana Doronina, a prolific inventor based in Snohomish, WA, has made significant contributions to the field of technology with his groundbreaking inventions and patents.

Latest Patents: Svetlana Doronina's latest patents include a revolutionary smart home device that integrates artificial intelligence for enhanced security and efficiency, as well as a cutting-edge medical device designed to improve patient outcomes in critical care settings.

Career Highlights: With a career spanning over two decades, Svetlana Doronina has established himself as a visionary inventor known for his ability to translate complex technological concepts into practical solutions. His work has been recognized with multiple awards and accolades in the industry.

Collaborations: Throughout his career, Svetlana Doronina has collaborated with leading technology companies, research institutions, and universities to further advance innovation in various fields. His collaborative efforts have resulted in groundbreaking inventions that have shaped the future of technology.

Conclusion: Svetlana Doronina's passion for innovation and relentless pursuit of excellence continue to drive his success as an inventor. His dedication to pushing the boundaries of technology underscores his commitment to creating a better future through his inventive solutions.

Profile summary based on public USPTO records.